Photon-counting detector computed tomography (PCD-CT) devices have recently been introduced into practice, despite photon-counting detector technology having been studied for many years. PCD-CT devices are expected to provide advantages in dose reduction, tissue specificity, artifact-free imaging, and multi-contrast demonstration capacity. Noise reduction and increased spatial resolution are expected using PCD-CT, even under challenging scanning conditions. Some experimental or preliminary studies support this hypothesis. This pictorial review illustrates the features of PCD-CT systems, particularly in the interventional field. PCD-CT offers superior image quality and better lesion discrimination than conventional CT techniques for various conditions. PCD-CT shows significant improvements in many aspects of vascular imaging. It is still in its early stages, and several challenges have been identified. Also, PCD-CT devices have some important caveats. The average cost of these devices is 3 to 4 times higher than conventional CT units. This additional cost must be justified by improved clinical benefits or reduced clinical harms. Further investigations will be needed to resolve these issues.